Benzodiazepine Use and Misuse Among Adults in the United States
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Goals were to determine the prevalence of benzodiazepine use (as prescribed and misuse), characterize misuse, and examine variation by age. METHODS: A cross-sectional analysis was conducted of 2015 and 2016 National Survey on Drug Use and Health data limited to adults ≥18 (N=86,186) and data from those respondents reporting benzodiazepine use (N=10,290). Measurements included past-year prescription benzodiazepine use and misuse ("any way a doctor did not direct"), substance use disorders, mental illness, and demographic characteristics. Misuse was compared between younger (18-49) and older (≥50) adults. RESULTS: A total of 30.6 million adults (12.6%) reported past-year benzodiazepine use-25.3 million (10.4%) as prescribed and 5.3 million (2.2%) misuse. Misuse accounted for 17.2% of overall use. Adults ages 50-64 had the highest prescribed use (12.9%). Those ages 18-25 had the highest misuse (5.2%), and those ages ≥65 had the lowest (.6%). Misuse and abuse of or dependence on prescription opioids or stimulants were strongly associated with benzodiazepine misuse. Benzodiazepine misuse without a prescription was the most common type of misuse, and a friend or relative was the most common source. Adults ages ≥50 were more likely than younger adults to use a benzodiazepine more often than prescribed and to use a benzodiazepine to help with sleep. CONCLUSIONS: Benzodiazepine use among U.S. adults was higher than previously reported, and misuse accounted for nearly 20% of use overall. Use by adults ages 50-64 now exceeds use by those ages ≥65. Patients also prescribed stimulants or opioids should be monitored for benzodiazepine misuse. Improved access to behavioral interventions for sleep or anxiety may reduce some misuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since benzodiazepines are among the most frequently prescribed drugs in the United States, treatments for BIND represent an urgent unmet medical need [25].”
From Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey (2023) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundMeta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons
Woolcott, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.357 · Cited by 1,326 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundExplicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly: An Update
Beers, M. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440350031003 · Cited by 1,059 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundPark, T. W., Saitz, R., Ganoczy, D., Ilgen, M. A., & Bohnert, A. S. B. (2015) · BMJ · doi:10.1136/bmj.h2698 · Cited by 579
Help-seeking behaviour in men and women with common mental health problems: cross-sectional study
Oliver, M. I., Pearson, N., Coe, N., & Gunnell, D. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.4.297 · Cited by 558 · cited 1×
“This may further support the hypothesis that higher misuse is partially a function of limited access to a prescribed option—limited for younger patients due to lack of insurance and for men due to minimal disclosure of mental health concerns to providers (42).”
BackgroundBenzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray, W. A. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430230088031 · Cited by 548 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundBenzodiazepine use, abuse, and dependence.
O’Brien, C. P. (2005) · PubMed · Cited by 539
Sun, E. C., Dixit, A., Humphreys, K., Darnall, B. D., Baker, L. C., & Mackey, S. (2017) · BMJ · doi:10.1136/bmj.j760 · Cited by 534
Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996–2013
Bachhuber, M. A., Hennessy, S., Cunningham, C. O., & Starrels, J. L. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303061 · Cited by 531 · cited 5×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundMethodInfluentialMedical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
Bradford, A. C., & Bradford, W. D. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1661 · Cited by 341
Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C., Quigg, M. S., Cohn, W. F., & Morin, C. M. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3249 · Cited by 325 · cited 1×
“The development of interventions such as web-based cognitive behavioral therapy for insomnia may help increase access to benzodiazepine alternatives for those who lack access to providers or insurance or both (35).”
BackgroundSertraline Treatment of Pathological Gambling: A Pilot Study
Saiz-Ruiz, J., Blanco, C., Ibáñez, A., Masramon, X., Gómez, M. M., Madrigal, M., & Díez, T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0104 · Cited by 293
Inappropriate Medication Use in Community-Residing Older Persons
Stuck, A. E. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.19.2195 · Cited by 278
Blazer, D. G., & Wu, L.-T. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318190b8ef · Cited by 242 · cited 2×
“The lack of information about misuse among older adults is particularly striking because they are prescribed benzodiazepines at the highest rates, are most at-risk of related adverse events, and are using alcohol and other substances more than prior cohorts (19, 20).”
BackgroundHospitalizations for Poisoning by Prescription Opioids, Sedatives, and Tranquilizers
Coben, J. H., Davis, S. M., Furbee, P. M., Sikora, R. D., Tillotson, R. D., & Bossarte, R. M. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.01.022 · Cited by 173 · cited 1×
“, anxiolytic or muscle relaxant) poisoning, the largest absolute growth was in benzodiazepine-related poisonings (11), while benzodiazepine-related overdose mortality grew nearly five-fold from 1996 to 2013 (1).”
BackgroundOur other prescription drug problem
Lembke, A., Papac, J., & Humphreys, K. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1715050 · Cited by 160 · cited 1×
“Concerns related to benzodiazepine prescribing have spread beyond just older adults or coprescribing with opioids (12).”
BackgroundA Systematic Review of Opioid and Benzodiazepine Misuse in Older Adults
Maree, R. D., Marcum, Z. A., Saghafi, E. M., Weiner, D. K., & Karp, J. F. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.06.003 · Cited by 143 · cited 1×
“A recent systematic review of benzodiazepine and opioid misuse in older adults (21) found just one study that estimated potential benzodiazepine misuse among older adults in the U.”
BackgroundBecker, W. C., Fiellin, D. A., & Desai, R. A. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.04.009 · Cited by 124 · cited 2×
“Most recent benzodiazepine-related work has focused either on misuse in the context of opioid use (14–16) or tranquilizer and/or sedative medication misuse but not benzodiazepines specifically (17, 18).”
BackgroundResultMaust, D. T., Blow, F. C., Wiechers, I. R., Kales, H. C., & Marcus, S. C. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m10713 · Cited by 93 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundSelf-citationImplications of the Accuracy of MEPS Prescription Drug Data for Health Services Research
Hill, S. C., Zuvekas, S. H., & Zodet, M. W. (2011) · INQUIRY: The Journal of Health Care Organization, Provision, and Financing · doi:10.5034/inquiryjrnl_48.03.04 · Cited by 92 · cited 1×
“MEPS respondents may underestimate the number of unique medications used in a year, specifically underreporting those used for a shorter duration or with fewer fills (46), which is how benzodiazepines may be prescribed.”
BackgroundBlazer, D., Hybels, C., Simonsick, E., & Hanlon, J. T. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04782.x · Cited by 91
Blazer, D. G., & Wu, L. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02306.x · Cited by 88 · cited 2×
“The lack of information about misuse among older adults is particularly striking because they are prescribed benzodiazepines at the highest rates, are most at-risk of related adverse events, and are using alcohol and other substances more than prior cohorts (19, 20).”
BackgroundAssessing Opioid Shopping Behaviour
Cepeda, M. S., Fife, D., Chow, W. S., Mastrogiovanni, G., & Henderson, S. C. (2012) · Drug Safety · doi:10.2165/11596600-000000000-00000 · Cited by 87
Treating Anxiety in 2017: Optimizing Care to Improve Outcomes
Stein, M. B., & Craske, M. G. (2017) · JAMA · doi:10.1001/jama.2017.6996 · Cited by 85
Long-term use of benzodiazepines and nonbenzodiazepine hypnotics, 1999-2014.
Kaufmann, C. N., Spira, A. P., Depp, C. A., & Mojtabai, R. (2018) · Psychiatric Services · doi:10.1176/appi.ps.201700095 · Cited by 85
No end in sight: benzodiazepine use in older adults in the United States.
Maust, D. T., Kales, H. C., Wiechers, I. R., Blow, F. C., & Olfson, M. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14379 · Cited by 82
Self-citationClinical Management of Insomnia Disorder
Buysse, D. J., Rush, A. J., & Reynolds, C. F. (2017) · JAMA · doi:10.1001/jama.2017.15683 · Cited by 82 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundToxicological Interactions Between Alcohol and Benzodiazepines
Tanaka, E. (2002) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-120002887 · Cited by 81 · cited 1×
“The association of alcohol abuse or dependence with increased odds of benzodiazepine misuse is particularly concerning in light of the increased potential for fatal poisoning when combined (36, 37).”
BackgroundSchepis, T. S., & McCabe, S. E. (2016) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.04.020 · Cited by 70 · cited 1×
“Most recent benzodiazepine-related work has focused either on misuse in the context of opioid use (14–16) or tranquilizer and/or sedative medication misuse but not benzodiazepines specifically (17, 18).”
BackgroundLinnoila, M. (1990) · Journal of Psychiatric Research · doi:10.1016/0022-3956(90)90043-p · Cited by 60 · cited 1×
“The association of alcohol abuse or dependence with increased odds of benzodiazepine misuse is particularly concerning in light of the increased potential for fatal poisoning when combined (36, 37).”
BackgroundExamining racial/ethnic differences in patterns of benzodiazepine prescription and misuse
Cook, B., Creedon, T., Wang, Y., Lu, C., Carson, N., Jules, P., Lee, E., & Alegría, M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.02.011 · Cited by 60
Cross-Cohort Differences in Health on the Verge of Retirement
Soldo, B. J., Mitchell, O. S., Tfaily, R., & McCabe, J. (2006) · National Bureau of Economic Research · doi:10.3386/w12762 · Cited by 44
Bouvier, B. A., Waye, K. M., Elston, B., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.10.023 · Cited by 44
Ladapo, J. A., Larochelle, M. R., Chen, A., Villalon, M. M., Vassar, S., Huang, D. Y. C., & Mafi, J. N. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0544 · Cited by 38
Cross-Cohort Differences in Health on the Verge of RetirementPreprint
Soldo, B. J., Mitchell, O. S., Tfaily, R., & McCabe, J. F. (2006) · SSRN Electronic Journal · doi:10.2139/ssrn.934621 · Cited by 37 · cited 1×
“In contrast, the aging Baby Boomers—who comprise nearly the entire 50–64 group in this analysis—have higher rates of alcohol and other substance use compared to aging adults before them (19, 20, 29).”
BackgroundCalcaterra, S. L., Severtson, S. G., Bau, G. E., Margolin, Z. R., Bucher‐Bartelson, B., Green, J., & Dart, R. C. (2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1457792 · Cited by 27
Greene, M., Chambers, R. A., Yiannoutsos, C. T., Wright, E. R., Steele, G. K., & Zollinger, T. W. (2017) · American Journal on Addictions · doi:10.1111/ajad.12639 · Cited by 7
Research works printed but not linked: 2
- Lipari RN, Williams M, Van Horn SL. Why Do Adults Misuse Prescription Drugs? 2017 7 27 In: The Center for Behavioral Health Statistics and Quality Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US) Available from: https://www.ncbi.nlm.nih.gov/books/NBK458284/ 28968046
- Center for Behavioral Health Statistics and Quality. (2016). 2015 National Survey on Drug Use and Health: Summary of the Effects of the 2015 NSDUH Questionnaire Redesign: Implications for Data Users. Substance Abuse and Mental Health Services Administration, Rockville, MD. 30199192
Cited by
The epidemiology of benzodiazepine misuse: A systematic review*
Votaw, V. R., Geyer, R., Rieselbach, M. M., & McHugh, R. K. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.033 · Cited by 479
Wilson, S., Anderson, K., Baldwin, D., Dijk, D.-J., Espie, A., Espie, C., Gringras, P., Krystal, A., Nutt, D., Selsick, H., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855343 · Cited by 312
“Despite the recommendation for treatment with hypnotic drugs being only 2–4 weeks, many millions of patients worldwide remain on long-term treatment (Ohayon et al., 1999; Maust et al., 2019).”
BackgroundBalancing the Risks and Benefits of Benzodiazepines
Hirschtritt, M. E., Olfson, M., & Kroenke, K. (2021) · JAMA · doi:10.1001/jama.2020.22106 · Cited by 96
Ngcobo, N. N. (2025) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01466-0 · Cited by 199
“Maust et al. observed that benzodiazepine usage increased with age among members of a large health maintenance organisation in the USA [97].”
Xu, K. Y., Hartz, S. M., Borodovsky, J. T., Bierut, L. J., & Grucza, R. A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.28557 · Cited by 94
Metadata
- Authors
- Maust, D. T., Lin, L. A., & Blow, F. C.
- Affiliations
- University of Michigan (US)
- Venue
- Psychiatric Services
- Published
- 2019-02-01
- Volume
- 70
- Issue
- 2
- Pages
- 97-106
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- PMC
- PMC6358464
- OpenAlex
- W2904755589
- Cited by
- 337
- References
- 42
- Citations by year
- 2026: 40 · 2025: 50 · 2024: 72 · 2023: 48 · 2022: 56 · 2021: 27 · 2020: 35 · 2019: 8
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychiatric Services (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01DA045705)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepine misuse, benzodiazepine use, prescription drug misuse, prevalence, age differences, substance use disorders, opioid misuse, stimulant abuse, sleep aids, benzodiazepine dependence, National Survey on Drug Use and Health
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Benzodiazepines, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Drug Prescriptions, United States, Prevalence, Young Adult, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.